Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

JAC-antimicrobial resistance

Showing results (1-10 of 1,294) with videos related to

Pageof 130
Sort By:
Jac-Antimicrobial Resistance|July 7, 2022
National surveillance of <i>Neisseria gonorrhoeae</i> antimicrobial susceptibility and epidemiological data of gonorrhoea patients across Brazil, 2018-20Hanalydia de Melo Machado, Jéssica Motta Martins, Marcos André Schörner, et al.
Jac-Antimicrobial Resistance|July 15, 2021
Antimicrobial use in hospitalized patients: a multicentre point prevalence survey across seven hospitals in GhanaAppiah-Korang Labi, Noah Obeng-Nkrumah, Nicholas T K D Dayie, et al.
Jac-Antimicrobial Resistance|July 15, 2021
<i>Educational Resource Review:</i> Antimicrobial stewardship e-learning modules
Jac-Antimicrobial Resistance|July 6, 2021
Erratum to: Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective studyAngela Dramowski, Gerald Ong'ayo, Andrea M Rehman, et al.
Jac-Antimicrobial Resistance|January 5, 2023
Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective studyAurélien Dinh, Clara Duran, Simrandeep Singh, et al.
Jac-Antimicrobial Resistance|January 5, 2023
The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative reviewLucy S Witt, Jessica R Howard-Anderson, Jesse T Jacob, et al.
Jac-Antimicrobial Resistance|January 5, 2023
Successful use of nafcillin and ceftaroline combination therapy for persistent MSSA bacteraemia and endocarditis: a case seriesErin F Warren, R Jake Crocker, Benjamin Tabor, et al.
Jac-Antimicrobial Resistance|January 5, 2023
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USATruc T Tran, Nicolo L Cabrera, Anne J Gonzales-Luna, et al.
Jac-Antimicrobial Resistance|January 16, 2023
The role of hospital antimicrobial and infectious diseases pharmacists in the UK: a theoretically underpinned explorationC Micallef, D A Enoch, P Kamranpour, et al.
Jac-Antimicrobial Resistance|January 16, 2023
<i>Staphylococcus aureus</i> bacteriuria: implications and managementC Y Mason, A Sobti, A L Goodman
Pageof 130

Showing results (1-10 of 1,294) with videos related to

Sort By:
Pageof 130
Jac-Antimicrobial Resistance|July 7, 2022
National surveillance of <i>Neisseria gonorrhoeae</i> antimicrobial susceptibility and epidemiological data of gonorrhoea patients across Brazil, 2018-20Hanalydia de Melo Machado, Jéssica Motta Martins, Marcos André Schörner, et al.
Jac-Antimicrobial Resistance|July 15, 2021
Antimicrobial use in hospitalized patients: a multicentre point prevalence survey across seven hospitals in GhanaAppiah-Korang Labi, Noah Obeng-Nkrumah, Nicholas T K D Dayie, et al.
Jac-Antimicrobial Resistance|July 15, 2021
<i>Educational Resource Review:</i> Antimicrobial stewardship e-learning modules
Jac-Antimicrobial Resistance|July 6, 2021
Erratum to: Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective studyAngela Dramowski, Gerald Ong'ayo, Andrea M Rehman, et al.
Jac-Antimicrobial Resistance|January 5, 2023
Real-life temocillin use in Greater Paris area, effectiveness and risk factors for failure in infections caused by ESBL-producing Enterobacterales: a multicentre retrospective studyAurélien Dinh, Clara Duran, Simrandeep Singh, et al.
Jac-Antimicrobial Resistance|January 5, 2023
The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative reviewLucy S Witt, Jessica R Howard-Anderson, Jesse T Jacob, et al.
Jac-Antimicrobial Resistance|January 5, 2023
Successful use of nafcillin and ceftaroline combination therapy for persistent MSSA bacteraemia and endocarditis: a case seriesErin F Warren, R Jake Crocker, Benjamin Tabor, et al.
Jac-Antimicrobial Resistance|January 5, 2023
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USATruc T Tran, Nicolo L Cabrera, Anne J Gonzales-Luna, et al.
Jac-Antimicrobial Resistance|January 16, 2023
The role of hospital antimicrobial and infectious diseases pharmacists in the UK: a theoretically underpinned explorationC Micallef, D A Enoch, P Kamranpour, et al.
Jac-Antimicrobial Resistance|January 16, 2023
<i>Staphylococcus aureus</i> bacteriuria: implications and managementC Y Mason, A Sobti, A L Goodman
Pageof 130